The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen’s UPLIZNA ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...
Columnist Juliet Taylor and her late husband, Jeff, fought hard for precious holiday moments after he was diagnosed with ALS.
The Muscular Dystrophy Association (MDA) recognizes the U.S. Food and Drug Administration (FDA) approval of Amgen's UPLIZNA(R) (inebilizumab-cdon) for the treatment of generalized myasthenia gravis ...
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
Highlights: FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS ...
A local man is using what time he has left to to raise awareness about the financial and emotional toll A-L-S, also known as ...
Tech companies, a charity and academics have collaborated to create AI-powered avatars that are helping people with motor ...
On November 17, 2025, Congressman Jason Crow introduced H.R. 6001, the Veterans with ALS Reporting Act. The purpose of this Act is to prioritize learning why disabled veterans are more likely than ...
A new wave of expressive, humanlike AI is helping people who cannot speak reclaim presence, connection, and dignity in ...
Slowing down in a fast-paced world while living with ALS isn’t surrendering, writes columnist. It’s an active choice to be ...
The Muscular Dystrophy Association (MDA) today announced more than $2.7 million in new research grants to advance groundbreaking discoveries across multiple neuromuscular diseases, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback